Related references
Note: Only part of the references are listed.Drug susceptibility patterns of rapidly growing mycobacteria isolated from skin and soft tissue infections in Venezuela
Omaira Da Mata-Jardin et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2020)
A Roadmap for the Development of Ivermectin as a Complementary Malaria Vector Control Tool
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2020)
Non-tuberculous mycobacterial infections-A neglected and emerging problem
Imran Ahmed et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
Safety of high-dose ivermectin: a systematic review and meta-analysis
Miriam Navarro et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)
Non-tuberculous mycobacteria and the rise of Mycobacterium abscessus
Matt D. Johansen et al.
NATURE REVIEWS MICROBIOLOGY (2020)
Ivermectin and COVID-19: Keeping Rigor in Times of Urgency
Carlos Chaccour et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2020)
State-of-the-art treatment strategies for nontuberculous mycobacteria infections
Maria-Carmen Munoz-Egea et al.
EXPERT OPINION ON PHARMACOTHERAPY (2020)
The Rise of Non-Tuberculosis Mycobacterial Lung Disease
Champa N. Ratnatunga et al.
FRONTIERS IN IMMUNOLOGY (2020)
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
Leon Caly et al.
ANTIVIRAL RESEARCH (2020)
Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline
Charles L. Daley et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Looking beyond Typical Treatments for Atypical Mycobacteria
Clara M. Bento et al.
ANTIBIOTICS-BASEL (2020)
Antimicrobial susceptibility testing of Mycobacteroides (Mycobacterium) abscessus complex, Mycolicibacterium (Mycobacterium) fortuitum, and Mycobacteroides (Mycobacterium) chelonae
Akio Aono et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2019)
Mycobacterium abscessus, an Emerging and Worrisome Pathogen among Cystic Fibrosis Patients
Giulia Degiacomi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Treatment of infections caused by nontuberculous mycobacteria
Jaime Esteban et al.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA (2018)
Management of nontuberculous mycobacterial pulmonary disease
Mark H. Adelman et al.
CURRENT OPINION IN PULMONARY MEDICINE (2018)
NTM drug discovery: status, gaps and the way forward
Mu-Lu Wu et al.
DRUG DISCOVERY TODAY (2018)
Toxicology of Avermectins and Milbemycins (Macrocyclic Lactones) and the Role of P-Glycoprotein in Dogs and Cats
Valentina M. Merola et al.
VETERINARY CLINICS OF NORTH AMERICA-SMALL ANIMAL PRACTICE (2018)
The macrolide antibiotic renaissance
George P. Dinos
BRITISH JOURNAL OF PHARMACOLOGY (2017)
Antimicrobial susceptibility testing of rapidly growing mycobacteria isolated in Japan
Shuji Hatakeyama et al.
BMC INFECTIOUS DISEASES (2017)
Human infections due to nontuberculous mycobacteria: the infectious diseases and clinical microbiology specialists' point of view
Lorenzo Guglielmetti et al.
FUTURE MICROBIOLOGY (2015)
Selamectin Is the Avermectin with the Best Potential for Buruli Ulcer Treatment
Nicole Scherr et al.
PLOS NEGLECTED TROPICAL DISEASES (2015)
Rapid Molecular Detection of Inducible Macrolide Resistance in Mycobacterium chelonae and M-abscessus Strains: a Replacement for 14-Day Susceptibility Testing?
Kimberly E. Hanson et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2014)
Ivermectin: panacea for resource-poor communities?
Satoshi Omura et al.
TRENDS IN PARASITOLOGY (2014)
Anthelmintic Avermectins Kill Mycobacterium tuberculosis, Including Multidrug-Resistant Clinical Strains
Leah E. Lim et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Ivermectin is a specific inhibitor of importin α/β-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus
Kylie M. Wagstaff et al.
BIOCHEMICAL JOURNAL (2012)
Macrocyclic Lactones in the Treatment and Control of Parasitism in Small Companion Animals
Thomas J. Nolan et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2012)
Mycobacterium abscessus: a new antibiotic nightmare
Rachid Nessar et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Moxidectin and the avermectins: Consanguinity but not identity
Roger Prichard et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2012)
Prevalence of erm methylase genes in clinical isolates of non-pigmented, rapidly growing mycobacteria
J. Esteban et al.
CLINICAL MICROBIOLOGY AND INFECTION (2009)
The pharmacokinetics and interactions of ivermectin in humans - A mini-review
Aranzazu Gonzalez Canga et al.
AAPS JOURNAL (2008)
Pharmacokinetics of selamectin following intravenous, oral and topical administration in cats and dogs
P Sarasola et al.
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS (2002)
Share Paper
